{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:17:58Z","timestamp":1790371078247,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,28]]},"DOI":"10.7759\/cureus.24552","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T13:17:46Z","timestamp":1651151866000},"source":"Crossref","is-referenced-by-count":5,"title":["Epstein-Barr Virus Reactivation Causing Cholestatic Hepatitis"],"prefix":"10.7759","author":[{"given":"Teresa","family":"Da Cunha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Mago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopjeet  K","family":"Bath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.77.3.1840-1847.2003","article-title":"Compartmentalization and transmission of multiple Epstein-Barr virus strains in asymptomatic carriers","volume":"77","author":"Sitki-Green D","year":"2003","unstructured":"Sitki-Green D, Covington M, Raab-Traub N. Compartmentalization and transmission of multiple Epstein-Barr virus strains in asymptomatic carriers. J Virol. 2003, 77:1840-7. 10.1128\/jvi.77.3.1840-1847.2003","journal-title":"J Virol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2016.0271","article-title":"Epstein-Barr virus-associated lymphomas","volume":"372","author":"Shannon-Lowe C","year":"2017","unstructured":"Shannon-Lowe C, Rickinson AB, Bell AI. Epstein-Barr virus-associated lymphomas. Philos Trans R Soc Lond B Biol Sci. 2017, 372:20160271. 10.1098\/rstb.2016.0271","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4172\/2469-5653.1000113","article-title":"Incidence of infectious mononucleosis in universities and U.S. military settings","volume":"5","author":"Williams-Harmon YJ","year":"2016","unstructured":"Williams-Harmon YJ, Jason LA, Katz BZ. Incidence of infectious mononucleosis in universities and U.S. military settings. J Diagn Tech Biomed Anal. 2016, 5:10.4172\/2469-5653.1000113","journal-title":"J Diagn Tech Biomed Anal"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2017.1319972","article-title":"Hepatitis due to Epstein-Barr virus and cytomegalovirus: clinical features and outcomes","volume":"52","author":"Leonardsson H","year":"2017","unstructured":"Leonardsson H, Hreinsson JP, L\u00f6ve A, Bj\u00f6rnsson ES. Hepatitis due to Epstein-Barr virus and cytomegalovirus: clinical features and outcomes. Scand J Gastroenterol. 2017, 52:893-7. 10.1080\/00365521.2017.1319972","journal-title":"Scand J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05122.x","article-title":"Characteristics of Epstein-Barr virus hepatitis among patients with jaundice or acute hepatitis","volume":"36","author":"Vine LJ","year":"2012","unstructured":"Vine LJ, Shepherd K, Hunter JG, et al.. Characteristics of Epstein-Barr virus hepatitis among patients with jaundice or acute hepatitis. Aliment Pharmacol Ther. 2012, 36:16-21. 10.1111\/j.1365-2036.2012.05122.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i35.5711","article-title":"Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients","volume":"12","author":"Petrova M","year":"2006","unstructured":"Petrova M, Muhtarova M, Nikolova M, Magaev S, Taskov H, Nikolovska D, Krastev Z. Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients. World J Gastroenterol. 2006, 12:5711-6. 10.3748\/wjg.v12.i35.5711","journal-title":"World J Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12525","article-title":"Hepatitis due to EBV-reactivation under infliximab in a psoriasis patient","volume":"30","author":"Sondermann W","year":"2017","unstructured":"Sondermann W, Baba HA, K\u00f6rber A. Hepatitis due to EBV-reactivation under infliximab in a psoriasis patient. Dermatol Ther. 2017, 30:e12525. 10.1111\/dth.12525","journal-title":"Dermatol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/530568","article-title":"Epstein-Barr virus reactivation after infliximab in rheumatoid arthritis: a case report","volume":"2011","author":"Colaci M","year":"2011","unstructured":"Colaci M, Sebastiani M, Sandri G, Meacci M, Ferri C. Epstein-Barr virus reactivation after infliximab in rheumatoid arthritis: a case report. Case Rep Infect Dis. 2011, 2011:530568. 10.1155\/2011\/530568","journal-title":"Case Rep Infect Dis"},{"key":"ref9","article-title":"Epstein-Barr virus-associated infectious mononucleosis and risk factor analysis for complications in hospitalized children","volume":"38","author":"Tsai MH","year":"2005","unstructured":"Tsai MH, Hsu CY, Yen MH, et al.. Epstein-Barr virus-associated infectious mononucleosis and risk factor analysis for complications in hospitalized children. J Microbiol Immunol Infect. 2005, 38:255-61.","journal-title":"J Microbiol Immunol Infect"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064921","article-title":"Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010","volume":"8","author":"Dowd JB","year":"2013","unstructured":"Dowd JB, Palermo T, Brite J, McDade TW, Aiello A. Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010. PLoS One. 2013, 8:e64921. 10.1371\/journal.pone.0064921","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1040-8428(02)00112-9","article-title":"Immunological aspects of Epstein-Barr virus infection","volume":"44","author":"Ohga S","year":"2002","unstructured":"Ohga S, Nomura A, Takada H, et al.. Immunological aspects of Epstein-Barr virus infection. Crit Rev Oncol Hematol. 2002, 44:203-15. 10.1016\/S1040-8428(02)00112-9","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/BF00870312","article-title":"Stress, loneliness, and changes in herpesvirus latency","volume":"8","author":"Glaser R","year":"1985","unstructured":"Glaser R, Kiecolt-Glaser JK, Speicher CE, Holliday JE. Stress, loneliness, and changes in herpesvirus latency. J Behav Med. 1985, 8:249-60. 10.1007\/BF00870312","journal-title":"J Behav Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/2319-4170.132905","article-title":"Epstein-Barr virus reactivation in critically ill immunocompetent patients","volume":"38","author":"Libert N","year":"2015","unstructured":"Libert N, Bigaillon C, Chargari C, Bensalah M, Muller V, Merat S, de Rudnicki S. Epstein-Barr virus reactivation in critically ill immunocompetent patients. Biomed J. 2015, 38:70-6. 10.4103\/2319-4170.132905","journal-title":"Biomed J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2018-0208-RA","article-title":"Epstein-Barr virus hepatitis: a review of clinicopathologic features and differential diagnosis","volume":"142","author":"Schechter S","year":"2018","unstructured":"Schechter S, Lamps L. Epstein-Barr virus hepatitis: a review of clinicopathologic features and differential diagnosis. Arch Pathol Lab Med. 2018, 142:1191-5. 10.5858\/arpa.2018-0208-RA","journal-title":"Arch Pathol Lab Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2020.00088","article-title":"Cytomegalovirus hepatitis in immunocompetent and immunocompromised hosts","volume":"9","author":"Da Cunha T","year":"2021","unstructured":"Da Cunha T, Wu GY. Cytomegalovirus hepatitis in immunocompetent and immunocompromised hosts. J Clin Transl Hepatol. 2021, 9:106-15. 10.14218\/JCTH.2020.00088","journal-title":"J Clin Transl Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.14309\/01.ajg.0000598832.07070.41","article-title":"2325 severe cholestatic hepatitis: an atypical presentation of Epstein-Barr virus infection","volume":"114","author":"Sanchez AJ","year":"2019","unstructured":"Sanchez AJ, Brown K, He X. 2325 severe cholestatic hepatitis: an atypical presentation of Epstein-Barr virus infection. Am J Gastroenterol. 2019, 114:1295-6. 10.14309\/01.ajg.0000598832.07070.41","journal-title":"Am J Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0676.1994.tb00001.x","article-title":"Manifestations of Epstein-Barr virus-associated disorders in liver","volume":"14","author":"Markin RS","year":"1994","unstructured":"Markin RS. Manifestations of Epstein-Barr virus-associated disorders in liver. Liver. 1994, 14:1-13. 10.1111\/j.1600-0676.1994.tb00001.x","journal-title":"Liver"},{"key":"ref18","article-title":"Fatal hepatitis during Epstein-Barr virus reactivation","volume":"7","author":"Cacopardo B","year":"2003","unstructured":"Cacopardo B, Nunnari G, Mughini MT, Tosto S, Benanti F, Nigro L. Fatal hepatitis during Epstein-Barr virus reactivation. Eur Rev Med Pharmacol Sci. 2003, 7:107-9.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.14740\/gr.v13i2.1283","article-title":"Reactivation of Epstein-Barr virus hepatitis in T\/natural killer (NK) cells mimicking liver T\/NK-cell lymphoma","volume":"13","author":"Kwong S","year":"2020","unstructured":"Kwong S, Kwong S, Lu X, et al.. Reactivation of Epstein-Barr virus hepatitis in T\/natural killer (NK) cells mimicking liver T\/NK-cell lymphoma. Gastroenterol Res. 2020, 13:81-4. 10.14740\/gr.v13i2.1283","journal-title":"Gastroenterol Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3641813","article-title":"Reactivation of Epstein-Barr virus presenting as massive splenomegaly after initiation of golimumab treatment","volume":"2020","author":"Febres-Aldana AJ","year":"2020","unstructured":"Febres-Aldana AJ, Febres-Aldana CA, Dvir K, Galarza-Fortuna G, Schwartz M, Medina AM, Sriganeshan V. Reactivation of Epstein-Barr virus presenting as massive splenomegaly after initiation of golimumab treatment. Case Rep Hematol. 2020, 2020:3641813. 10.1155\/2020\/3641813","journal-title":"Case Rep Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/95172-epstein-barr-virus-reactivation-causing-cholestatic-hepatitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:21Z","timestamp":1707507561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/95172-epstein-barr-virus-reactivation-causing-cholestatic-hepatitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.24552","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,28]]}}}